Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$264.41
+3.59%
Mkt Cap $5.10B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (16 analysts)
$249.33
Range $230.00 – $275.00
Implied Upside
-5.7%
Consensus $249.33 vs current $264.41